Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5705_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •1.1.4 Components of niosome
- •1.1.5 Factors affecting niosomes
- •Preface
- •Abstract
- •1.1 Introduction
- •1.1.1 Why niosome?
- •1.1.2 Advantages of niosome
- •1.1.3 Structure of niosome
- •1.2 Applications of niosome
- •1.2.2 Niosomes for the delivery of therapeutics
- •1.2.3 Niosomes in biomedical applications
- •1.3 Conclusions and future prospects
- •Keywords
- •References
- •Abstract
- •2.1 Introduction
- •2.2 Conclusions
- •Acknowledgments
- •Keywords
- •References
- •Abstract
- •3.1 Introduction
- •3.2.1 Parameters involved in electrospinning process
- •3.2.2 Biomaterials for electrospinning
- •3.3 Electrospun nanofibers as drug delivery systems
- •3.3.1 Blending electrospinning
- •3.3.2 Emulsion electrospinning
- •3.3.3 Coaxial electrospinning
- •3.3.4 Surface modifications
- •3.4 Electrospun nanofibers for tissue engineering
- •3.4.1 Electrospun nanofibers for hard tissue engineering
- •3.5 Cancer diagnosis and therapy
- •3.6 Concluding remarks and future perspectives
- •Keywords
- •References
- •4. Natural Biocarriers for Brain Targeting
- •Abstract
- •4.1 Introduction
- •4.1.1 Central nervous system
- •4.2 Biocarriers
- •4.2.1 Carbohydrates carriers
- •4.2.2 Protein carriers
- •4.2.3 Exosomes
- •4.3 Conclusions and perspectives
- •Keywords
- •References
- •Abstract
- •5.1 Introduction
- •5.2 Synthesis of graphene family nanomaterials
- •5.2.1 Graphene synthesis
- •5.2.2 GO and rGO Syntheses
- •5.2.3 GQd synthesis
- •5.4 Drug delivery and biomedical applications
- •5.4.1 Drug delivery
- •5.4.2 Gene delivery
- •5.4.3 Bioimaging
- •5.4.4 Photothermal therapy
- •5.4.5 Tissue engineering
- •5.5 Summary and future prospect
- •Keywords
- •References
- •6. Nanotechnology in Gene Delivery
- •Abstract
- •6.1 Introduction
- •6.2 Gene delivery
- •6.3 Nanotechnology in gene delivery
- •Keywords
- •References
- •Abstract
- •7.1 Introduction
- •7.2 Additive manufacturing in pharmacology
- •7.2.1 Extrusion-based 3D printing techniques
- •7.2.2 Stereolithography
- •7.2.3 Selective laser sintering
- •7.2.4 Binder jet printing
- •7.3 Most common polymers
- •7.3.1 Natural polymers
- •7.3.2 Synthetic polymers
- •7.3.2.5 Polyvinylpyrrolidone
- •7.4 Common 3D-printed dosage forms
- •7.4.1 Scaffolds
- •7.4.2 Tablets
- •Keywords
- •References
- •7.4.3 Microneedles
- •7.4.4 Capsule
- •7.4.5 Films
- •7.5 Main factors in drug delivery
- •7.5.1 Nature of polymers
- •7.5.2 Matrix permeability
- •7.5.3 Polymer blends
- •7.5.4 Specific surface area
- •7.5.5 Infill density and patterns
- •7.5.6 Pores
- •7.5.7 Cross-linking
- •7.5.8 Coating
- •7.5.9 Core/shell and multicompartment
- •7.6 Final considerations and future perspectives
- •Abstract
- •8.1 Introduction
- •8.2.1 Polymer solution concentration and viscosity
- •8.2.2 Molecular weight of polymer
- •8.2.3 Surface tension
- •8.2.4 Electrical conductivity
- •8.2.5 Applied voltage
- •8.2.6 Feed rate/flow rate
- •8.2.7 Temperature and humidity
- •8.3 Method of preparation for nanofibers
- •8.3.1 Electrospinning
- •8.3.2 Self-assembly
- •8.3.3 Phase separation
- •8.3.4 Drawing of nanofibers
- •8.3.5 Template synthesis
- •8.4 Biomedical applications of nanofibers
- •8.4.1 Wound dressing
- •8.4.2 Tissue engineering
- •8.4.3 In cancer therapy
- •8.4.4 Miscellaneous
- •8.5 Drug delivery application
- •8.5.1 Antihypertensive drug
- •8.5.2 Antimicrobial drug
- •8.5.3 Growth hormone
- •8.5.4 Miscellaneous
- •8.6 Conclusion
- •Keywords
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Tissue engineering
- •9.3 Nanotechnology
- •9.4 Polymeric scaffolds in tissue engineering
- •9.5 Challenges
- •Keywords
- •References
- •Abstract
- •10.1 Introduction
- •10.2 Ideal properties of bioceramics
- •10.2.1 Mechanical property
- •10.2.2 Porosity, pore size, and shape
- •10.2.3 Biocompatibility and biodegradability
- •10.2.4 Osteoconductivity and osseointegrity
- •10.3 Bioceramics in orthopedic applications
- •10.4 Bioceramics in maxillofacial surgery
- •10.5 Bioceramic in drug delivery applications
- •10.6 Doped bioceramic in biomedical application
- •10.7 Conclusions
- •10.8 Future direction
- •Acknowledgments
- •Keywords
- •References
- •Index

228
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Polym. Eng. Sci. 2018, 58 (12),
2119–2132.
Int. J. Pharm. 2021, 597,
120336.
Global Issues and Its Applications. Int. J. Biol. Macromol. 2021, 185, 832–848.
Biomed. Eng.
Online 2020, 19 (1), 1–33.
Polymers 2022, 14 (5), 857.
Arrays. Adv. Healthc. Mater. 2021, 10 (13), 2001922.
Prog. Polym. Sci. 2019, 96, 1–20.
2023, 79, 104028.
Mater. Sci. Eng. C 2021, 120, 110144.
Medical Devices Using CLIP and Drug-Loaded Liquid Resins. J. Contr olled Release 2018,
278, 9–23.
ACS Appl.
Mater. Interfaces 2022, 14 (11), 12964–12975.
Filaments. Pharmaceutics 2021, 13 (11), 1857.
(FDM) 3D Printing. Int. J. Pharm. 2020, 591, 119987.
J.
Controlled Release 2021, 330, 821–8
41.
Delivery Systems. Eur. Polym. J. 2020, 129, 109621.
Math. Biosci. 2019, 315, 108216.

3D Printed Devices as Drug Delivery Systems
229
Pharmaceutics 2021, 13 (11), 1866.
J. Drug Delivery Sci. Technol. 2020, 55,
101393.
J. Pharmaceut. Innov. 2020, 15 (1), 163–181.
Polymers
2020, 12 (7), 1455.
Mater. Sci. Eng. C 2019a, 104, 109842.
Int. J.
Nanomed. 2012, 7, 4285.
ACS Nano 2016, 10 (1), 93–101.
Colloids Surf. B 2019b, 179, 121–127.
Int. J.
Pharm. 2020, 591, 119983.
Drug Products. Pharmaceutics 2019, 11 (12), 672.
Partially Deacetylated Chitins. Biomacromolecules 2000, 1 (4), 609–614.
Partially Deacetylated Chitins. 2000, 1 (4), 609–614.
Biomed.
Microdevices 2010, 12 (2), 263–273.
Carbohydr. Polym. 2019, 221, 55–62.
Int. J. Pharm. 2022, 613, 121411.

230
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Pharmaceuticals
2021, 14 (5), 418.
Int. J. Pharm. 2022, 618, 121679.
J. Drug Delivery Sci.
Technol. 2020, 57, 101683.
J. Drug Delivery Sci. Technol. 2022, 70,
103208.
Pharmaceutical Applications. Expert opinion on drug delivery 2016, 13 (9), 1257–1275.
systems. Mater. Today Chem. 2020, 16, 100248.
Biofabrication 2019, 11 (3),
035014.
Polymer in Biomedical Applications. Prog. Polym. Sci. 2011, 36 (8), 981–1014.
Carbohydr. Polym. 2021, 273, 118537.
Delivery. Adv. Drug. Deliv. Rev. 2004, 56 (5), 659–674.
Ann. Biomed. Eng. 2017, 45 (1), 297–305.
Int. J.
Pharm. 2018, 552 (1–2), 217–224.
Surgery. Pharmaceutics 2020, 12 (1), 63.
ACS Appl. Mater . Interfaces 2018,
10 (11), 9247–9256.
®
: A Versatile Family
Pharmaceutics 2021, 13 (9), 1424.
Experiments (DOE) Approach. Int. J. Pharm. 2021, 597, 120331.

3D Printed Devices as Drug Delivery Systems
231
Engineering. Acta Biomater. 2010, 6 (12), 4495–4505.
2021, 610,
121194.
Int. J. Pharm. 2021,
610, 121194.
Drug Delivery. Int. J. Pharmaceut. 2018, 544 (2), 415–424.
Int. J. Pharm. 2021, 605, 120854.
Int. J. Pharm. 2020, 590, 119868.
In-Process Drying. Int. J. Pharm. 2020, 575, 118883.
Eur. J. Pharm.
Biopharm. 2019, 144, 180–192.
Int. J. Pharm. 2021, 607, 121002.
J. Drug Delivery Sci. Technol. 2022, 75, 103660.
Eur. Polym.
J. 2019, 114, 90–97.
Bioprinting 2021, 24, e00174.
Int. J. Polym. Mater. 2020, 69 (4), 230–247.
3D Printing. J. Drug Delivery Sci. Technol. 2022, 74, 103558.
Applications and Opportunities. 3D printing of pharmaceuticals
2018, 81–105.
Laser Sintering. Int. J. Pharm. 2018, 547 (1–2), 44–52.
Order Release Printlets. Polymers 2020, 12 (8), 1769.

232
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Printed Orally Disintegrating Printlets Using Selective Laser Sintering. Int. J. Pharm. 2018,
541 (1–2), 101–107.
Polymers 2020, 12 (5), 1114.
Int. J. Pharm. 2018, 549 (1–2), 370–379.
Nanocomposites. Molecules 2015, 20 (12), 22833–22847.
Expert Rev. Med. Devices 2011, 8 (4), 459–482.
J. Controlled
Release 2017, 268, 40–48.
Food science and nutrition 2019, 7 (11), 3363–3377.
Drug Discovery
Today 2019, 24 (2), 636–643.
and Fused Deposition Modeling. Pharmaceutics 2020, 12 (1), 77.
Diabetic Wound-Healing Applications. Drug Deliv. Transl. Res. 2022, 1–14.
Diabetic Wound-Healing Applications. Drug Deliv. Transl. Res. 2022, 1–14.
Int. J. Pharm. 2022, 121872.
Polymers 2020, 12
(6), 1269.
Int. J. Pharm.
2014, 476 (1–2), 88–92.
Eur. J. Pharm. Biopharm. 2015, 89,
157–162.
Int. J. Pharm. 2015, 494 (2), 657–663.

3D Printed Devices as Drug Delivery Systems
233
Drug Release Characteristics. Mol. Pharmaceut. 2015, 12 (11), 4077–4084.
Pharmaceutics 2021, 13 (10), 1701.
Drug Bioavailability in Ocular Drug Delivery Systems. Pharmaceuticals 2021, 14 (11),
1201.
and Ribavirin Dose. Ann. Intern. Med. 2004, 140 (5), 346–355.
Drug Delivery. Int. J. Pharm. 2021, 604, 120759.
Stereolithography. 2019, 11 (12), 645.
Cellulose 2020, 27 (3), 1573–1589.
Proc. Inst. Mech. Eng., Part C: J. Mech. Eng. Sci. 2003, 217 (1),
31–39.
J. Pharm. Investig. 2021, 51 (2), 213–222.
Processes
2020, 8 (9), 1138.
US4575330A, 1986. 2019.
J. Controlled
Release 2022, 351, 215–230.
Journal of the Mechanical Behavior of
Materials 2017, 26 (5–6), 213–222.
ACS
Biomater. Sci. Eng. 2018, 5
(2), 846–858.
Obstet. Gynecol. Surv. 2015, 70 (10), 612–614.
Pharmaceutics 2022,
14 (4), 834.

234
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Adv. Healthcar e
Mater. 2019, 8 (20), 1900379.
Mater. Today Adv. 2022, 15, 100259.
Compos. B: Eng. 2019, 164, 287–296.
Int. J. Pharm. 2021, 597, 120304.
Pharmaceutics 2021, 13 (12), 2143.
Absorption. Int. J. Pharm. 2018, 544 (1), 285–296.
Drug Delivery. Asian J. Pharm. Sci. 2016, 11 (5), 559–574.
Pharmaceutics 2021, 13 (7), 1096.
Int. J. Pharm. Sci. Rev. Res 2014, 28 (1), 214–221.
Loaded Implants. Eur. J. Pharm. Biopharm. 2017, 115, 84–93.
Drug Deliv. Transl. Res. 2022, 12 (5), 1195–1208.
Int.
J. Pharm. 2018, 545 (1–2), 144–152.
Pharmaceutics
2022, 14 (5), 1082.
COVID-19 Inhibition. J. Drug Delivery Sci. Technol.
2020, 60, 102046.
J. Controlled Release 2017, 261, 207–215.
Adv. Mater. Interfaces
2022, 9 (23), 2201186.

3D Printed Devices as Drug Delivery Systems
235
Nat. Nanotechnol. 2016, 11 (6),
566–572.
Sci. Adv. 2017, 3 (3), e1601314.
ACS Biomater. Scie. Eng.
2018, 4 (1), 278–289.
Recent Progress in Drug Delivery. Acta Pharm. Sin. B 2019, 9 (6), 1145–1162.
Molecules 2020, 25 (21), 5023.
Engineering. Front. Bioeng. Biotechnol. 2021, 9, 662381.
Curr. Med. Chem. 2017, 24 (22), 2413–2422.
Int. J. Pharm. 2017, 525 (1), 5–11.
Pharmaceutics 2022, 14 (2), 437.
Pharmaceutics 2021, 13 (4), 471.
Delivery. J. Controlled Release 2022, 347, 489–499.
Pharmacokinetic Modeling. Pharmaceutics 2021, 14 (1), 20.
ACS Appl. Mater.
Interfaces 2019, 11 (42), 39179–39191.
Oral Delivery Device: A First-In-Human Study. Sci. Adv . 2018,
4 (5), eaat2544.
Delivery. Eur. J. Pharm. Biopharm. 2019, 134, 138–143.
Acta
Biomater. 2021, 131, 314–325.

236
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Nanomaterials 2021, 11 (9), 2456.
Macromol.
Biosci. 2021, 21 (4), 2000398.
Precision and Application in Food Sector. 2017, 69, 83–94.
Mater.
Sci. Eng. C 2019, 104, 109873.
Enhanced Autonomous Drug Delivery. Adv. Mater. 2020, 32 (1), 1905740.
Delivery Systems. J. Controlled Release 2006, 111 (1–2), 212–218.
Sci. Rep. 2019, 9 (1),
1–11.
Pharmaceutics 2021,
13 (11), 1969.
Int. J. Biol. Macromol. 2021, 188, 820–832.
J. Controlled Release
2017, 268, 10–18.
Mater. Sci. Eng. C 2019, 94, 426–436.
Mater. Sci. Eng. C 2019, 101, 15–26.
International Journal of Bioprinting 2021, 7 (4).
Int. J. Biol. Macromol.
2022, 205, 90–109.
Delivery. Science 1995, 269 (5225), 850–853.

3D Printed Devices as Drug Delivery Systems
237
Printing. Pharmaceutics 2022, 14 (4), 871.
Int. J. Pharm.
2022, 623, 121960.
and Challenges. Prog. Mater Sci. 2021, 119, 100707.
Ni-Mn-Ga Magnetic Shape Memory Alloy Foam. Acta Mater. 2017, 131, 482–490.
Macromol. Biosci. 2022, 22 (4), 2100442.
Adv. Drug. Deliv. Rev. 2017,
108, 39–50.
Int. J. Pharm. 2021, 610, 121261.
Int. J. Pharm. 2021, 601, 120507.
and Drug Release. Aaps. Pharmscitech. 2019, 20 (2), 1–13.
and Liquid Dispensing. Eur. J. Pharm. Sci. 2018, 118, 134–143.
Plasticised HPMCAS. Int. J. Pharm. 2022, 616, 121553.
J. Drug Delivery Sci. Technol. 2022, 74, 103505.
Int. J.
Pharm. 2020, 579, 119169.
Mater.
Des. 2022, 215, 110480.
Pharmaceutics
2022, 14 (2), 443.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
